中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2015年
23期
3750-3754
,共5页
干细胞%诱导%心脏干细胞%缺氧诱导因子%心肌梗死%细胞移植%基因载体%基因转染
榦細胞%誘導%心髒榦細胞%缺氧誘導因子%心肌梗死%細胞移植%基因載體%基因轉染
간세포%유도%심장간세포%결양유도인자%심기경사%세포이식%기인재체%기인전염
Heart%Myocardial Infarction%Hypoxia-Inducible Factor 1,alpha Subunit%Stem Cell Transplantation
背景:心脏干细胞移植到心肌梗死区,可以有效改善心室重塑,提高心脏功能,但移植细胞在梗死区的缺氧微环境中存活率较低。研究表明缺氧诱导因子1α可在缺氧条件下稳定表达,同时增加心肌细胞的活性及存活能力。目的:分别从心脏干细胞的特点,缺氧诱导因子1α保护心脏的作用机制,载体的选择及移植途径等方面来具体阐述缺氧诱导因子1α基因转染心脏干细胞治疗心肌梗死的研究进展。方法:应用计算机检索CNKI和PubMed数据库中2000年1月至2015年1月关于心脏干细胞和缺氧诱导因子1α的文章,在标题和摘要中以“心脏干细胞、缺氧诱导因子1α、移植途径”或“Cardiac stem cels, Hypoxia Inducible Factor 1(HIF-1a), gene delivery”为检索词进行检索,最终选择关于心脏干细胞、缺氧诱导因子1、基因载体的37篇文献进行综述。结果与结论:多项研究证实缺氧诱导因子1α可以在缺氧的环境中提高心脏干细胞的生存率。大量动物实验证实了心脏干细胞和缺氧诱导因子1α对梗死缺氧区域具有保护和修复作用。目前缺氧诱导因子1α基因转染心脏干细胞尚未有成功的报道,但并不影响研究者对相关领域的探索,相信在不久的未来,基因修饰心脏干细胞将会在临床得到广泛应用。
揹景:心髒榦細胞移植到心肌梗死區,可以有效改善心室重塑,提高心髒功能,但移植細胞在梗死區的缺氧微環境中存活率較低。研究錶明缺氧誘導因子1α可在缺氧條件下穩定錶達,同時增加心肌細胞的活性及存活能力。目的:分彆從心髒榦細胞的特點,缺氧誘導因子1α保護心髒的作用機製,載體的選擇及移植途徑等方麵來具體闡述缺氧誘導因子1α基因轉染心髒榦細胞治療心肌梗死的研究進展。方法:應用計算機檢索CNKI和PubMed數據庫中2000年1月至2015年1月關于心髒榦細胞和缺氧誘導因子1α的文章,在標題和摘要中以“心髒榦細胞、缺氧誘導因子1α、移植途徑”或“Cardiac stem cels, Hypoxia Inducible Factor 1(HIF-1a), gene delivery”為檢索詞進行檢索,最終選擇關于心髒榦細胞、缺氧誘導因子1、基因載體的37篇文獻進行綜述。結果與結論:多項研究證實缺氧誘導因子1α可以在缺氧的環境中提高心髒榦細胞的生存率。大量動物實驗證實瞭心髒榦細胞和缺氧誘導因子1α對梗死缺氧區域具有保護和脩複作用。目前缺氧誘導因子1α基因轉染心髒榦細胞尚未有成功的報道,但併不影響研究者對相關領域的探索,相信在不久的未來,基因脩飾心髒榦細胞將會在臨床得到廣汎應用。
배경:심장간세포이식도심기경사구,가이유효개선심실중소,제고심장공능,단이식세포재경사구적결양미배경중존활솔교저。연구표명결양유도인자1α가재결양조건하은정표체,동시증가심기세포적활성급존활능력。목적:분별종심장간세포적특점,결양유도인자1α보호심장적작용궤제,재체적선택급이식도경등방면래구체천술결양유도인자1α기인전염심장간세포치료심기경사적연구진전。방법:응용계산궤검색CNKI화PubMed수거고중2000년1월지2015년1월관우심장간세포화결양유도인자1α적문장,재표제화적요중이“심장간세포、결양유도인자1α、이식도경”혹“Cardiac stem cels, Hypoxia Inducible Factor 1(HIF-1a), gene delivery”위검색사진행검색,최종선택관우심장간세포、결양유도인자1、기인재체적37편문헌진행종술。결과여결론:다항연구증실결양유도인자1α가이재결양적배경중제고심장간세포적생존솔。대량동물실험증실료심장간세포화결양유도인자1α대경사결양구역구유보호화수복작용。목전결양유도인자1α기인전염심장간세포상미유성공적보도,단병불영향연구자대상관영역적탐색,상신재불구적미래,기인수식심장간세포장회재림상득도엄범응용。
BACKGROUND:Cardiac stem cels transplanted to the myocardial infarction area can effectively improve ventricular remodeling and promote heart function. But the survival rate of transplanted cels is lower in the infracted area under hypoxic microenvironment. Hypoxia inducing factor 1 alpha under anoxic conditions can stably express, and meanwhile increase the activity and survival ability of myocardial cels. OBJECTIVE:To elaborate the research progress in hypoxia inducing factor 1 alpha-transfected cardiac stem cels for treatment of myocardial infarction from the folowing aspects: cardiac stem cel characteristics, mechanism underlying myocardial protection of hypoxia inducing factor 1 alpha, selection of carriers and transplantation approach. METHODS: A computer-based search of CNKI and PubMed was performed for articles related to cardiac stem cels and hypoxia inducing factor 1 alpha published from January 2000 to January 2015. The keywords were “cardiac stem cels, hypoxia inducible factor 1(HIF-1a), gene delivery” in Chinese and English, respectively, which appeared in the title and abstract. Finaly, 37 relevant articles were enroled in result analysis. RESULTS AND CONCLUSION:Several studies have confirmed that hypoxia inducing factor 1 alpha can improve the survival rate of cardiac stem cels under anoxic conditions. Increasing evidences from animal experiments have shown that cardiac stem cels and hypoxia inducing factor 1 alpha exert protective and repairing effects on myocardial infarction. Currently, there is no successful report about hypoxia inducing factor 1 alpha gene transfection of cardiac stem cels, but relevant studies are proceeding. Gene modified cardiac stem cels are expected to be widely used in clinic.